Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency
Executive summary of the Th ird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring human plasma copper-binding peptide known to possess wound healing, antioxidant, anti-inflammatory, and antiaging effects [3]
GLP-1 Pipeline Update: May 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
basis for Rybelsus obesity indication making it the first oral GLP-1 RA approved for obesity
This Recommendation is based on results of three observational studies that used high-pressure (e.g., systolic blood pressure, mean arterial pressure) and/or long duration (e.g., repeated intervals of 30 minutes, 3 hours continuously)
